Chimerix

$2.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.02 (0.92%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Chimerix and other stocks, options, ETFs, and crypto commission-free!

About CMRX

Chimerix, Inc. Common Stock, also called Chimerix, is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Read More Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.

Employees
59
Headquarters
Durham, North Carolina
Founded
2000
Market Cap
134.79M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
321.02K
High Today
$2.23
Low Today
$2.19
Open Price
$2.19
Volume
237.11K
52 Week High
$4.40
52 Week Low
$1.74

Collections

CMRX Earnings

-$0.47
-$0.41
-$0.35
-$0.29
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 7, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.